JOURNAL OF ELECTROCARDIOLOGY, cilt.39, sa.2, ss.211-218, 2006 (SCI-Expanded, Scopus)
Objective: We sought to examine the effect of trimetazidine (TMZ) on heart rate variability (HRV), endothelin-1 (ET-1), NO, and anginal symptoms in patients with slow coronary artery flow (SCAF).